Vito Di Marco

Summary

Country: Italy

Publications

  1. ncbi request reprint HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy
    Vito Di Marco
    Cattedra e Unità Operativa Complessa di Gastroenterologia ed Epatologia, University of Palermo, Palermo, Italy
    Antivir Ther 10:431-9. 2005
  2. ncbi request reprint Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection
    Giovanni Squadrito
    Dipartimento di Medicina Interna, Universita di Messina, Italy
    Am J Gastroenterol 97:1518-23. 2002
  3. ncbi request reprint HCV clearance among hemophiliacs and beta-thalassemics
    Vito Di Marco
    Gastroenterology 132:1634. 2007
  4. pmc IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection
    Vito Di Marco
    Sezione di Gastroenterologia ed Epatologia, DiBiMIS, University of Palermo, Piazza delle Cliniche 2, 90127 Palermo, Italy
    Haematologica 97:679-86. 2012
  5. ncbi request reprint High-dose prolonged combination therapy in non-responders to interferon monotherapy for chronic hepatitis C
    V Di Marco
    Cattedra e Divisione di Gastroenterologia, University of Palermo, Italy
    Aliment Pharmacol Ther 15:953-8. 2001
  6. doi request reprint Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel
    Vito Di Marco
    Italian Society for the Study of Thalassemia and Haemoglobinopathies, Rome, Italy
    Blood 116:2875-83. 2010
  7. doi request reprint Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) - lack of interference by iron deposition
    Vito Di Marco
    Dipartimento Biomedico di Medicina Interna e Specialistica Di Bi M I S, Unità Complessa di Gastroenterologia ed Epatologia, University of Palermo, Palermo, Italy
    Br J Haematol 148:476-9. 2010
  8. doi request reprint Chronic hepatitis B: who to treat and which choice of treatment?
    Vito Di Marco
    Dipartimento Biomedico di Medicina Interna e Specialistica, Gastroenterology and Hepatology Unit, University of Palermo, Palermo, Italy
    Expert Rev Anti Infect Ther 7:281-91. 2009
  9. doi request reprint Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C
    Vito Di Marco
    Dipartimento Biomedico di Medicina Interna e Specialistica, DiBiMIS, University of Palermo, Piazza delle Cliniche 2, 90127 Palermo, Italy
    Haematologica 93:1243-6. 2008
  10. ncbi request reprint Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension: a randomized controlled trial
    Vito Di Marco
    Cattedra di Gastroenterologia and Unità Operativa Complessa di Gastroenterologia ed Epatologia, Di Bi M I S, Piazza delle Cliniche 2, 90127 Palermo, Italy
    J Hepatol 47:484-91. 2007

Detail Information

Publications51

  1. ncbi request reprint HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy
    Vito Di Marco
    Cattedra e Unità Operativa Complessa di Gastroenterologia ed Epatologia, University of Palermo, Palermo, Italy
    Antivir Ther 10:431-9. 2005
    ..Profound and maintained HBV-DNA suppression correlates with a better outcome. Early identification of LAM resistance mutations allows switching to other antivirals before liver decompensation or hepatocellular carcinoma development...
  2. ncbi request reprint Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection
    Giovanni Squadrito
    Dipartimento di Medicina Interna, Universita di Messina, Italy
    Am J Gastroenterol 97:1518-23. 2002
    ..We aimed to assess the HBV and HCV virological profiles in cases of coinfection and to evaluate the relationship between HCV core gene variability and HBV activity...
  3. ncbi request reprint HCV clearance among hemophiliacs and beta-thalassemics
    Vito Di Marco
    Gastroenterology 132:1634. 2007
  4. pmc IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection
    Vito Di Marco
    Sezione di Gastroenterologia ed Epatologia, DiBiMIS, University of Palermo, Piazza delle Cliniche 2, 90127 Palermo, Italy
    Haematologica 97:679-86. 2012
    ..Polymorphisms in the interleukin-28B are important determinants in the spontaneous and drug-induced control of hepatitis C virus infection...
  5. ncbi request reprint High-dose prolonged combination therapy in non-responders to interferon monotherapy for chronic hepatitis C
    V Di Marco
    Cattedra e Divisione di Gastroenterologia, University of Palermo, Italy
    Aliment Pharmacol Ther 15:953-8. 2001
    ..Therapy of chronic hepatitis C non- responders to interferon monotherapy with standard doses of interferon plus ribavirin is usually ineffective...
  6. doi request reprint Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel
    Vito Di Marco
    Italian Society for the Study of Thalassemia and Haemoglobinopathies, Rome, Italy
    Blood 116:2875-83. 2010
    ....
  7. doi request reprint Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) - lack of interference by iron deposition
    Vito Di Marco
    Dipartimento Biomedico di Medicina Interna e Specialistica Di Bi M I S, Unità Complessa di Gastroenterologia ed Epatologia, University of Palermo, Palermo, Italy
    Br J Haematol 148:476-9. 2010
    ..0-100.0) and 95% specificity (95% CI: 84.2-99.3). Transient elastography is a reliable non-invasive tool for diagnosing advanced liver fibrosis in homozygous-beta-thalassaemics, regardless of the degree of iron overload...
  8. doi request reprint Chronic hepatitis B: who to treat and which choice of treatment?
    Vito Di Marco
    Dipartimento Biomedico di Medicina Interna e Specialistica, Gastroenterology and Hepatology Unit, University of Palermo, Palermo, Italy
    Expert Rev Anti Infect Ther 7:281-91. 2009
    ..Patients with compensated or decompensated cirrhosis should be treated, even if alanine aminotransferase levels are normal and/or serum HBV DNA levels are low, in order to prevent disease flare and to improve liver function...
  9. doi request reprint Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C
    Vito Di Marco
    Dipartimento Biomedico di Medicina Interna e Specialistica, DiBiMIS, University of Palermo, Piazza delle Cliniche 2, 90127 Palermo, Italy
    Haematologica 93:1243-6. 2008
    ..Adequate chelation therapy usually prevents the development of liver fibrosis in thalassemics free of hepatitis virus C-infection and reduces the risk of developing severe fibrosis in thalassemics with chronic hepatitis C...
  10. ncbi request reprint Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension: a randomized controlled trial
    Vito Di Marco
    Cattedra di Gastroenterologia and Unità Operativa Complessa di Gastroenterologia ed Epatologia, Di Bi M I S, Piazza delle Cliniche 2, 90127 Palermo, Italy
    J Hepatol 47:484-91. 2007
    ..Risks and benefits of antiviral therapy in HCV cirrhosis with portal hypertension are poorly known...
  11. ncbi request reprint Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine
    Vito Di Marco
    Cattedra e U O C di Gastroenterologia, Clinica Medica, Universita di Palermo, Palermo, Italy
    Hepatology 40:883-91. 2004
    ..After 4 years of therapy, 39% of patients maintain a virological and biochemical response. Loss of virological response may lead to clinical deterioration in patients with cirrhosis...
  12. ncbi request reprint Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction
    V Di Marco
    Cattedra di Gastroenterologia, Clinica Medica, University of Palermo, Palermo, Italy
    J Viral Hepat 9:354-9. 2002
    ..The rate of sustained response is a function of the time to HCV-RNA clearance. In patients not responding to induction therapy addition of ribavirin does not obtain a sustained virological response...
  13. doi request reprint Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection
    Salvatore Petta
    Cattedra ed Unità Operativa di Gastroenterologia, University of Palermo, Palermo, Italy
    Am J Gastroenterol 103:1136-44. 2008
    ..We aimed to assess whether increasing degrees of IR, up to overt diabetes, are linked to steatosis and higher stages of fibrosis in patients with CHC resulting from genotype 1 HCV (G1-HCV)...
  14. ncbi request reprint Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection
    Salvatore Petta
    Cattedra ed Unità Operativa di Gastroenterologia, Universita di Palermo, Palermo, Italy
    Antivir Ther 14:631-9. 2009
    ..We aimed to evaluate the time course of IR in response to antiviral therapy in non-diabetic, non-cirrhotic G1 HCV patients and to assess the effect of metabolic factors on sustained virological response (SVR)...
  15. ncbi request reprint HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin
    Isabella Abbate
    Department of Virology, National Institute for Infectious Diseases L Spallanzani, Rome, Italy
    J Hepatol 40:831-6. 2004
    ..HVR-1 quasispecies composition and evolution were investigated in patients chronically infected with genotype 1b HCV, treated with PEG-IFN alpha 2b or STD-IFN alpha 2b plus RBV...
  16. doi request reprint Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C
    Salvatore Petta
    Sezione di Gastroenterologia, DiBiMIS, University of Palermo, Palermo, Italy
    Antivir Ther 17:823-31. 2012
    ..We assessed whether 25-hydroxyvitamin D (25[OH]D) serum levels are linked to RVR and can be used together with IL28B to construct a pretreatment model to predict RVR...
  17. doi request reprint Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1
    Salvatore Petta
    Dipartimento Biomedico di Medicina Interna e Specialistica, Cattedra di Gastroenterologia, DiBiMIS, Palermo, Italy
    Hepatology 52:1543-52. 2010
    ..04), and fibrosis (OR 2.608, 95% CI 1.565-4.345, P < 0.001) were independently associated with moderate to severe necroinflammatory activity. No independent associations were found between VAI score and both fibrosis and SVR...
  18. doi request reprint Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection
    Salvatore Petta
    Sezione di Gastroenterologia, University of Palermo, Palermo, Italy
    Liver Int 31:507-15. 2011
    ..We aimed to assess the prevalence and the factors related to steatosis and IR in CHB patients, compared with CHC subjects, and to evaluate the potential association between these features and fibrosis severity...
  19. ncbi request reprint Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: a randomized controlled trial
    Giuseppe Alaimo
    Cattedra di Gastroenterologia, University of Palermo, Piazza delle Cliniche 2, Palermo 90127, Italy
    World J Gastroenterol 12:6861-4. 2006
    ..To assess the efficacy of different schedules of consensus interferon (CIFN) plus ribavirin in retreating chronic hepatitis C patients who relapsed after recombinant interferon (rIFN) monotherapy...
  20. doi request reprint IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease
    Salvatore Petta
    Sezione di Gastroenterologia, DiBiMIS, University of Palermo, Italy
    J Hepatol 56:1356-62. 2012
    ..The main outcomes of the study were to assess whether IL28B rs12979860 and rs8099917 polymorphisms, together with PNPLA3 rs738409 C>G polymorphism, are associated with lobular inflammation and fibrosis, in NAFLD patients...
  21. doi request reprint Carotid atherosclerosis and chronic hepatitis C: a prospective study of risk associations
    Salvatore Petta
    Sezione di Gastroenterologia, Di Bi M I S, Universita di Palermo, Italia
    Hepatology 55:1317-23. 2012
    ..3%) with F3-F4 fibrosis (P = 0.008). By contrast, in patients >55 years the prevalence of carotid plaques was similar in those with or without severe fibrosis (25/43, 58.1% versus 22/43, 51.1%; P = 0.51)...
  22. ncbi request reprint Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C
    Calogero Cammà
    Unità Operativa di Gastroenterologia, University of Palermo, Italy
    Hepatology 43:64-71. 2006
    ..IR is a risk factor for moderate/severe steatosis, especially in men. Moderate/severe steatosis has clinical relevance, being associated with advanced fibrosis and hyporesponsiveness to antiviral therapy...
  23. doi request reprint Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases
    Daniela Cabibi
    Dipartimento di Patologia Umana, University of Palermo, Italy
    Dig Liver Dis 42:585-92. 2010
    ....
  24. doi request reprint Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis
    Calogero Cammà
    Cattedra and Unità Operativa di Gastroenterologia, Di Bi M I S, University of Palermo, Italy
    Hepatology 49:195-203. 2009
    ....
  25. pmc PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease
    Salvatore Petta
    Di Bi M I S, Sezione di Gastroenterologia, Universita di Palermo, Palermo, Italia
    PLoS ONE 8:e74089. 2013
    ..To evaluate if the presence of carotid atherosclerosis in patients with NAFLD, could be related to gene variants influencing hepatic fat accumulation and the severity of liver damage...
  26. ncbi request reprint ISDR pattern and evolution in patients with chronic hepatitis C treated with standard or PEG-IFN plus ribavirin
    Giuseppina Cappiello
    National Institute for Infectious Diseases L Spallanzani, Rome, Italy
    Antivir Ther 8:105-10. 2003
    ..Thus, in our patients the baseline pattern of ISDR was unrelated to treatment outcome. Selection towards a dominant IFN-resistant strain did not occur under standard or PEG-IFN plus RBV...
  27. doi request reprint Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C
    Salvatore Petta
    Cattedra ed Unità Operativa di Gastroenterologia, DiBiMIS, University of Palermo, Italy
    Hepatology 51:1158-67. 2010
    ..Conclusion: G1 CHC patients had low 25(OH)D serum levels, possibly because of reduced CYP27A1 expression. Low vitamin D is linked to severe fibrosis and low SVR on interferon (IFN)-based therapy...
  28. pmc Serum γ-glutamyl transferase levels, insulin resistance and liver fibrosis in patients with chronic liver diseases
    Salvatore Petta
    Sezione di Gastroenterologia, DiBiMIS, University of Palermo, Palermo, Italy
    PLoS ONE 7:e51165. 2012
    ....
  29. doi request reprint High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis
    Salvatore Petta
    Sezione di Gastroenterologia, DiBiMIS, University of Palermo, Italy
    Dig Liver Dis 43:404-10. 2011
    ..To investigate the hepatic expression of retinol-binding protein-4 (RBP4) in chronic hepatitis C (CHC) and nonalcoholic steatohepatitis (NASH) patients, and its association with biochemical and histological patterns of liver damage...
  30. ncbi request reprint Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial
    Savino Bruno
    Clinica Medica, Ospedale San Paolo and Liver Unit, Ospedale Fatebenefratelli e Oftalmico, Milano, Italy
    J Hepatol 41:474-81. 2004
    ..We assessed the effectiveness and safety of an induction dose of peginterferon alfa-2b (PEG-IFN) plus ribavirin for initial treatment of patients with genotype 1 chronic HCV infection in a randomized, controlled, multicenter trial...
  31. ncbi request reprint Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always coeliac disease?
    Oreste Lo Iacono
    University of Palermo, Gastroenterology and Hepatology Unit, Palermo, Italy
    Am J Gastroenterol 100:2472-7. 2005
    ..In this population the efficacy of screening for CD by anti-tissue transglutaminase (anti-tTG) may be impaired by the high rate of positive anti-tTG found in chronic liver disease...
  32. doi request reprint Evaluating the risk of hepatitis B reactivation in patients with haematological malignancies: is the serum hepatitis B virus profile reliable?
    Donatella Ferraro
    Cattedra di Virologia, Dipartimento di Scienze per la Promozione della Salute G D Alessandro, University of Palermo, Sicily, Italy
    Liver Int 29:1171-7. 2009
    ....
  33. ncbi request reprint Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients
    Isabella Abbate
    Microbiology and Virology Service, S Pertini Hospital, Rome, Italy
    J Med Virol 70:581-7. 2003
    ....
  34. doi request reprint Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1
    Salvatore Petta
    Cattedra ed Unità Operativa di Gastroenterologia, University of Palermo, Palermo, Italy
    Hepatology 48:28-37. 2008
    ..045; 95% confidence interval, 1.020 to 1.070; P = 0.0004), whereas waist circumference was associated with moderate-severe steatosis in NAFLD (odds ratio, 1.095; 95% confidence interval, 1.007 to 1.192; P = 0.03)...
  35. pmc Survival of patients with hepatocellular carcinoma (HCC) treated by percutaneous radio-frequency ablation (RFA) is affected by complete radiological response
    Giuseppe Cabibbo
    Dipartimento Biomedico di Medicina Interna e Specialistica, Sezione di Gastroenterologia, Universita di Palermo, Palermo, Italia
    PLoS ONE 8:e70016. 2013
    ..Radio-frequency ablation (RFA) has been employed in the treatment of Barcelona Clinic Liver Cancer (BCLC) early stage hepatocellular carcinoma (HCC) as curative treatments...
  36. ncbi request reprint Body mass index and liver stiffness affect accuracy of ultrasonography in detecting steatosis in patients with chronic hepatitis C virus genotype 1 infection
    Fabio Salvatore Macaluso
    Sezione di Gastroenterologia, Dipartimento Biochimico di Medicina Interna e Specialistica, University of Palermo, Palermo, Italy Electronic address
    Clin Gastroenterol Hepatol 12:878-884.e1. 2014
    ..We assessed its accuracy in detecting steatosis and factors that affect its diagnostic performance in consecutive patients with chronic hepatitis C virus genotype 1 infection...
  37. doi request reprint Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients
    Salvatore Petta
    Sezione di Gastroenterologia, DiBiMIS, University of Palermo, Italy Electronic address
    J Hepatol 59:1169-76. 2013
    ..In a cohort of patients with genotype 1 chronic hepatitis C (G1 CHC), we tested the association of fructose intake with the severity of liver histology...
  38. doi request reprint Phylogenetic analysis of isolates from new cases of HBV infection in Southern Italy
    Donatella Ferraro
    Sezione di Microbiologia, Dipartimento di Scienze per la Promozione della Salute G D Alessandro, Universita degli Studi di Palermo, Palermo, Italy
    Infect Genet Evol 12:1591-6. 2012
    ..The introduction of new genotypes , could have an effect on HBV-correlated diseases due to the different association between genotype, liver disease and response to antiviral therapy...
  39. doi request reprint Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance
    Tommaso Stroffolini
    Dipartimento Malattie Infettive e Tropicali, Policlinico Umberto I, Rome, Italy
    Dig Liver Dis 43:875-80. 2011
    ..The aetiological factors of hepatocellular carcinoma may vary over time...
  40. pmc Hyperferritinemia is a risk factor for steatosis in chronic liver disease
    Anna Licata
    Gastroenterology and Hepatology Unit, Department of Internal Medicine, University of Palermo, 90127 Palermo, Italy
    World J Gastroenterol 15:2132-8. 2009
    ..To investigate the relationship between ferritin and steatosis in patients with chronically abnormal liver function tests (LFTs) and high ferritin level...
  41. ncbi request reprint Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study
    Calogero Cammà
    Cattedra e Unità Operativa di Gastroenterologia, University of Palermo, Palermo, Italy
    J Hepatol 42:535-40. 2005
    ..To assess the effectiveness and the safety of radio-frequency thermal ablation (RFTA) in patients with hepatocellular carcinoma (HCC) < or = 5 cm in compensated cirrhosis...
  42. pmc Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study
    Giuseppe Cabibbo
    Giuseppe Cabibbo, Marcello Maida, Chiara Genco, Pietro Parisi, Marco Peralta, Michela Antonucci, Giuseppe Brancatelli, Calogero Cammà, Antonio Craxì, Vito Di Marco, Section of Gastroenterology, Department of Internal Medicine and Biomedical Specialist, University of Palermo, Palermo 90127, Italy
    World J Hepatol 4:256-61. 2012
    ..To investigate the clinical course of untreatable hepatocellular carcinoma (HCC) identified at any stage and to identify factors associated with mortality...
  43. ncbi request reprint Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C
    Calogero Cammà
    Sezione di Gastroenterologia, Di Bi M I S, University of Palermo, Italy
    Hepatology 56:850-60. 2012
    ..42 with TVR-IL28B. ICER compared with DT was € 8.304 per LYG for BOC-RVR and € 11.455 per LYG for TVR-IL28B. The model was highly sensitive to IL28B CC genotype, likelihood of RVR and sustained virologic response, and BOC/TVR prices...
  44. pmc Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease
    Salvatore Petta
    Sezione di Gastroenterologia, Dipartimento Biomedico di Medicina Interna e Specialistica, University of Palermo, Palermo, Italy
    PLoS ONE 9:e87523. 2014
    ..We aimed to assess whether GCKR rs780094 C→T SNP influences the expression of steatosis, lobular inflammation and fibrosis in NAFLD patients, after correction for PNPLA3 genotype...
  45. doi request reprint Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study
    Tommaso Stroffolini
    Department of Infectious and Tropical Diseases, University La Sapienza, Rome, Italy
    J Med Virol 81:1999-2006. 2009
    ....
  46. ncbi request reprint Congenital hepatic fibrosis: a very uncommon cause of pancytopenia in children
    Antonino Trizzino
    Onco Ematologia Pediatrica, Ospedale dei Bambini G Di Cristina, Palermo, Italy
    J Pediatr Hematol Oncol 27:567-8. 2005
    ..The authors report an unusual case of ARPKD presenting with hepatosplenomegaly and cytopenia mimicking acute leukemia...
  47. doi request reprint Halitosis: could it be more than mere bad breath?
    Giuseppina Campisi
    Sector of Oral Medicine, Department of Oral Sciences, University of Palermo, Via del Vespro 129, 90127, Palermo, Italy
    Intern Emerg Med 6:315-9. 2011
    ..Extra-oral disorders can be the cause in up to 15% of cases...
  48. ncbi request reprint Adefovir for lamivudine resistant HBV: more than meets the eye
    Vito Di Marco
    J Hepatol 47:618-9; author reply 619-20. 2007
  49. ncbi request reprint Combination therapy with amantadine and interferon in naïve patients with chronic hepatitis C: meta-analysis of individual patient data from six clinical trials
    Alessandra Mangia
    Division of Gastroenterology, Ospedale Casa Sollievo Sofferenza, IRCCS, San Giovanni Rotondo 71013, Italy
    J Hepatol 40:478-83. 2004
    ..We performed a meta-analysis of the individual patient's data from previous studies...
  50. ncbi request reprint [Iron overload disease: recent findings]
    Anna Licata
    Istituto di Clinica Medica I, Universita degli Studi di Palermo
    Ann Ital Med Int 19:145-54. 2004
    ....
  51. ncbi request reprint [Radiofrequency thermoablation in the treatment of primary and secondary liver tumours]
    Luigi Sandonato
    Unità Interdipartimentale per lo Screening, la Diagnosi ed il Trattamento delle Neoplasie Epatiche, Universita degli Studi di Palermo
    Chir Ital 56:117-26. 2004
    ....